Vivani Medical (VANI) Competitors $1.06 +0.01 (+0.95%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.06 -0.01 (-0.47%) As of 04/17/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VANI vs. STIM, NVRO, RCEL, NYXH, INGN, ELMD, DRTS, PDEX, LNSR, and BWAYShould you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Neuronetics (STIM), Nevro (NVRO), AVITA Medical (RCEL), Nyxoah (NYXH), Inogen (INGN), Electromed (ELMD), Alpha Tau Medical (DRTS), Pro-Dex (PDEX), LENSAR (LNSR), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. Vivani Medical vs. Neuronetics Nevro AVITA Medical Nyxoah Inogen Electromed Alpha Tau Medical Pro-Dex LENSAR BrainsWay Neuronetics (NASDAQ:STIM) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability. Does the MarketBeat Community favor STIM or VANI? Neuronetics received 123 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 68.62% of users gave Neuronetics an outperform vote. CompanyUnderperformOutperformNeuroneticsOutperform Votes12968.62% Underperform Votes5931.38% Vivani MedicalOutperform Votes6100.00% Underperform VotesNo Votes Do analysts prefer STIM or VANI? Neuronetics currently has a consensus target price of $5.50, suggesting a potential upside of 46.28%. Vivani Medical has a consensus target price of $4.00, suggesting a potential upside of 277.36%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts clearly believe Vivani Medical is more favorable than Neuronetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, STIM or VANI? Vivani Medical has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuronetics$74.89M3.30-$30.19M-$1.37-2.74Vivani MedicalN/AN/A-$25.65M-$0.44-2.41 Which has more risk and volatility, STIM or VANI? Neuronetics has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.76, indicating that its share price is 176% more volatile than the S&P 500. Does the media favor STIM or VANI? In the previous week, Vivani Medical had 7 more articles in the media than Neuronetics. MarketBeat recorded 8 mentions for Vivani Medical and 1 mentions for Neuronetics. Vivani Medical's average media sentiment score of 0.41 beat Neuronetics' score of -1.00 indicating that Vivani Medical is being referred to more favorably in the news media. Company Overall Sentiment Neuronetics Negative Vivani Medical Neutral Is STIM or VANI more profitable? Vivani Medical has a net margin of 0.00% compared to Neuronetics' net margin of -50.09%. Vivani Medical's return on equity of -102.42% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Neuronetics-50.09% -141.24% -32.77% Vivani Medical N/A -102.42%-49.21% Do institutionals & insiders have more ownership in STIM or VANI? 53.6% of Neuronetics shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 9.8% of Neuronetics shares are held by company insiders. Comparatively, 44.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryVivani Medical beats Neuronetics on 12 of the 17 factors compared between the two stocks. Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VANI vs. The Competition Export to ExcelMetricVivani MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.79M$3.10B$5.30B$7.34BDividend YieldN/A1.79%5.45%4.30%P/E Ratio-2.3614.8721.8617.80Price / SalesN/A43.57380.5497.74Price / CashN/A44.0938.2634.64Price / Book2.593.336.453.98Net Income-$25.65M$94.03M$3.22B$247.81M1 Month Performance-3.64%-9.04%-9.71%-7.84%1 Year Performance-37.65%-20.29%11.51%1.60% Vivani Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VANIVivani Medical2.815 of 5 stars$1.06+1.0%$4.00+277.4%-41.3%$62.79MN/A-2.3620Analyst ForecastShort Interest ↑Gap UpSTIMNeuronetics1.6088 of 5 stars$3.55+0.6%$5.50+54.9%-1.8%$232.33M$74.89M-2.89180Short Interest ↑Positive NewsGap UpNVRONevro0.8923 of 5 stars$5.85+0.1%$6.43+9.9%-52.5%$224.32M$408.52M-3.091,215Analyst ForecastRCELAVITA Medical1.094 of 5 stars$7.76+3.5%$17.25+122.3%+3.8%$203.45M$64.25M-3.25130NYXHNyxoah2.0891 of 5 stars$5.71-6.1%$14.75+158.3%-42.0%$194.48M$4.52M-3.05110Short Interest ↑Gap UpINGNInogen3.1673 of 5 stars$7.09+0.7%$7.00-1.3%-3.8%$190.63M$335.71M-3.151,030Short Interest ↓High Trading VolumeELMDElectromed1.0457 of 5 stars$22.16-1.0%$38.00+71.5%+63.5%$189.62M$59.63M29.55160Positive NewsDRTSAlpha Tau Medical2.6506 of 5 stars$2.45-2.8%$8.00+226.5%-3.4%$172.43MN/A-5.7080Short Interest ↓News CoverageGap DownHigh Trading VolumePDEXPro-Dex1.5497 of 5 stars$52.87+3.9%$52.00-1.6%+223.9%$172.41M$61.00M26.30140Short Interest ↑News CoveragePositive NewsGap DownHigh Trading VolumeLNSRLENSAR0.9722 of 5 stars$13.76-0.6%$15.00+9.0%+343.0%$162.22M$53.49M-9.42110Short Interest ↓High Trading VolumeBWAYBrainsWay3.6416 of 5 stars$8.61-2.7%$13.17+52.9%+72.0%$162.10M$41.02M86.11120Short Interest ↓Positive NewsGap Down Related Companies and Tools Related Companies STIM Competitors NVRO Competitors RCEL Competitors NYXH Competitors INGN Competitors ELMD Competitors DRTS Competitors PDEX Competitors LNSR Competitors BWAY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VANI) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
